Type : Contract
VACCINES ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE MEDIATED DISEASES Solicitation ID/Procurement Identifier: 75N93022R00009 Ultimate Completion Date: Fri Sep 29 17:00:00 GMT 2028
VACCINES ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE MEDIATED DISEASES Solicitation ID/Procurement Identifier: 75N93022R00009 Ultimate Completion Date: Fri Sep 29 17:00:00 GMT 2028
DEVELOPMENT OF VACCINES FOR INFLUENZA USING AN IMMUNO-MODULATOR ADJUVANT AND MULTI-PLATFORM APPROACH Solicitation ID/Procurement Identifier: 75N93022R00009 Ultimate Completion Date: Fri Sep 29 17:00:00 GMT 2028
of a Simian Immunodeficiency Virus (SIV) and Simian Human Immunodeficiency Virus (SHIV) DatabaseTopic 114 - Point-of-Care HIV Viral Load, Drug Resistance, and Adherence AssaysTopic 115 - Development of Diagnostics to Differentiate HIV Infection from Vaccine-Induced SeropositivityTopic 116 - Adjuvant Discovery for Vaccines for Infectious and Immune-Mediated DiseasesTopic 117 - Adjuvant Development for Vaccines for Infectious and Immune-Mediated DiseasesTopic
As one component of the VRC’s research, the VRC, NIAID, NIH has been investigating the use of novel adjuvants in our vaccine development program for HIV, influenza and other viral vaccines, and has found the “Adjuplex brand” of adjuvant from Advanced BioAdjuvants LLC (ABA) to be superior to other adjuvants.
Vaccines against Infectious or Immune-mediated Diseases.- Adjuvant Development for Vaccines against Infectious or Immune-mediated Diseases.- Production of Adjuvants.- Reagents for Immunologic Analysis of Non-mammalian and Underrepresented Mammalian Models.- Antiviral drugs to cure chronic hepatitis B virus infection.- Broad spectrum antibody against human enteroviruses.- Development of rapid fungal diagnostics for select endemic dimorphic fungi.CENTER
DEVELOPMENT OF MEMBRANE ANCHORED CYTOKINES AS NOVEL VACCINE ADJUVANTS FOR THE ELDERLY. Solicitation ID/Procurement Identifier: PHS20171 Ultimate Completion Date: Mon Aug 15 17:00:00 GMT 2022
for HIV Vaccines - Effective Targeted Delivery of RNA-based Vaccines and Therapeutics - Methods Improving HIV Protein Expression: Cell Substrate and Protein Purification - Reagents for Immunologic Analysis of Non-mammalian and Underrepresented Mammalian Models - B Cell Receptor and T Cell Receptor Repertoire Computational Tools - Development of Sample Sparing Assay - Adjuvant Discovery for Vaccines and for Autoimmune and Allergic Diseases - Adjuvant